92 related articles for article (PubMed ID: 18005203)
1. Novel therapies in urothelial carcinoma: a biomarker-driven approach.
Iyer G; Rosenberg JE
Ann Oncol; 2018 Dec; 29(12):2302-2312. PubMed ID: 30016395
[TBL] [Abstract][Full Text] [Related]
2. ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer.
Fulton B; Jones R; Powles T; Crabb S; Paul J; Birtle A; Chowdhury S; Hussain S; Morris A; Soulis E; Morrison P
Trials; 2020 Apr; 21(1):344. PubMed ID: 32306987
[TBL] [Abstract][Full Text] [Related]
3. Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma.
Kurtoglu M; Davarpanah NN; Qin R; Powles T; Rosenberg JE; Apolo AB
Clin Genitourin Cancer; 2015 Oct; 13(5):410-20. PubMed ID: 25862322
[TBL] [Abstract][Full Text] [Related]
4. ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.
Powles T; Bellmunt J; Comperat E; De Santis M; Huddart R; Loriot Y; Necchi A; Valderrama BP; Ravaud A; Shariat SF; Szabados B; van der Heijden MS; Gillessen S;
Ann Oncol; 2024 Jun; 35(6):485-490. PubMed ID: 38490358
[No Abstract] [Full Text] [Related]
5. Editorial Comment to Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.
Kondo T
Int J Urol; 2024 May; 31(5):560-561. PubMed ID: 38424666
[No Abstract] [Full Text] [Related]
6. Editorial Comment on Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.
Ishihara H; Takagi T
Int J Urol; 2024 May; 31(5):559-560. PubMed ID: 38366784
[No Abstract] [Full Text] [Related]
7. The co-expression of antigen targets as a rationale for ADC combination in urothelial cancer.
Bertucci F; de Nonneville A; Finetti P; Cohendet A; Guille A; Mamessier E
Ann Oncol; 2024 May; 35(5):477-478. PubMed ID: 38364991
[No Abstract] [Full Text] [Related]
8. Metastasis-directed therapy among urological malignancies: where do we stand?
Re C; Stewart GD; Capitanio U
Curr Opin Urol; 2024 Jul; 34(4):258-260. PubMed ID: 38835186
[No Abstract] [Full Text] [Related]
9. Inactivation of p53 and Pten promotes invasive bladder cancer.
Puzio-Kuter AM; Castillo-Martin M; Kinkade CW; Wang X; Shen TH; Matos T; Shen MM; Cordon-Cardo C; Abate-Shen C
Genes Dev; 2009 Mar; 23(6):675-80. PubMed ID: 19261747
[TBL] [Abstract][Full Text] [Related]
10. Novel agents for advanced bladder cancer.
Sonpavde G; Elfiky AA; Rosenberg JE
Ther Adv Med Oncol; 2009 Jul; 1(1):37-50. PubMed ID: 21789112
[TBL] [Abstract][Full Text] [Related]
11. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
Sternberg CN
Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
[TBL] [Abstract][Full Text] [Related]
12. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Milowsky MI; Stadler WM; Bajorin DF
BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
[TBL] [Abstract][Full Text] [Related]
13. Novel agents for muscle-invasive and advanced urothelial cancer.
Sonpavde G; Ross R; Powles T; Sweeney CJ; Hahn N; Hutson TE; Galsky MD; Lerner SP; Sternberg CN
BJU Int; 2008 Apr; 101(8):937-43. PubMed ID: 18005203
[TBL] [Abstract][Full Text] [Related]
14. Treatment of metastatic urothelial cancer: opportunities for drug discovery and development.
Sonpavde G; Sternberg CN
BJU Int; 2008 Nov; 102(9 Pt B):1354-60. PubMed ID: 19035904
[TBL] [Abstract][Full Text] [Related]
15. Current optimal chemotherapy for advanced urothelial cancer.
Sonpavde G; Galsky MD; Hutson TE
Expert Rev Anticancer Ther; 2008 Jan; 8(1):51-61. PubMed ID: 18095883
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
